Follow-on offering Announced
Park Ha Biological Technology Co. equity raising
US$2.5m raised
Announced 26 Jan 2026 · NASDAQ: BYAH
Advisers
Park Ha Biological Technology Co.
Issuer
- Legal adviser
- Concord & Sage PCJiangsu Junjin law Firm
Lead managers
- Legal adviser
- Placement agent
- Issuer
- Park Ha Biological Technology Co.
- Issuer based in
- China
- Sector
- Consumer Health
Similar deals
- Xenitra placement (May 2026) May 2026 · US$889,625 · Consumer Health
- EVE Health Group placement (April 2025) Apr 2025 · US$639,000 · Pharma
- Enhanced Group placement Jun 2026 · US$50m · Healthcare Services
Sources
- 28 Jan 2026 Final IPO prospectus (424B4), Park Ha Biological Technology Co., Ltd. sec.gov